| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Premium | $11.47B+27.9% | $8.97B+57.8% | $5.69B+46.9% | $3.87B+111.4% | $1.83B+302.4% | $455.0M-2.9% | $468.9M |
| Investment income | $202.9M+9.3% | $185.7M+19.5% | $155.4M+463.3% | $27.6M+1099.2% | $2.3M-70.4% | $7.8M-59.8% | $19.3M |
| Other revenues | $28.6M+39.0% | $20.6M-3.6% | $21.4M-67.1% | $64.9M+1103.7% | $5.4M | $0 | — |
| Total revenue | $11.70B+27.5% | $9.18B+56.5% | $5.86B+47.9% | $3.96B+115.6% | $1.84B+297.3% | $462.8M-5.2% | $488.2M |
| Medical | $10.02B+36.6% | $7.33B+58.0% | $4.64B+41.5% | $3.28B+102.0% | $1.62B+425.0% | $309.4M-24.2% | $408.3M |
| Selling, general, and administrative | $2.05B+16.8% | $1.76B+23.1% | $1.43B+13.4% | $1.26B | — | — | — |
| Depreciation and amortization | $28.9M-10.1% | $32.1M+4.7% | $30.7M+100.8% | $15.3M-94.2% | $265.1M+59.1% | $166.7M+50.6% | $110.7M |
| Total operating expenses | $12.10B+32.6% | $9.12B+49.6% | $6.10B+33.9% | $4.55B+91.1% | $2.38B+175.5% | $865.1M+15.7% | $747.6M |
| Earnings (loss) from operations | -$396.4M-792.1% | $57.3M+124.3% | -$235.6M+60.1% | -$589.9M-8.3% | -$544.5M-35.4% | -$402.3M-55.1% | -$259.4M |
| Interest expense | $17.6M-25.8% | $23.7M-3.5% | $24.6M+8.8% | $22.6M+379.3% | $4.7M+34.3% | $3.5M | $0 |
| Other expenses | $23.3M+22127.6% | $105K-98.5% | $7.1M+393.3% | -$2.4M-301.1% | $1.2M | — | — |
| Earnings (loss) before income taxes | -$437.3M-1408.3% | $33.4M+112.5% | -$267.3M+56.2% | -$610.1M-6.9% | -$570.6M-40.6% | -$405.8M-56.4% | -$259.4M |
| Income tax expense | $5.6M-23.3% | $7.3M+121.8% | $3.3M+729.8% | -$523K-161.8% | $846K-19.0% | $1.0M-41.7% | $1.8M |
| Net income (loss) | -$442.9M-1795.6% | $26.1M+109.7% | -$270.6M+55.6% | -$609.6M-6.7% | -$571.4M-40.5% | -$406.8M-55.8% | -$261.2M |
| Less: Net income attributable to noncontrolling interests | $248K-64.0% | $689K+414.2% | $134K+104.1% | -$3.3M-377.7% | $1.2M | $0 | $0 |
| Net income (loss) attributable to Oscar Health, Inc. | -$443.2M-1842.5% | $25.4M+109.4% | -$270.7M+55.3% | -$606.3M-5.9% | -$572.6M-40.7% | -$406.8M-55.8% | -$261.2M |
| Basic (in dollars per share) | -$1690.00-1636.4% | $110.00+109.0% | -$1220.00+57.2% | -$2850.00+10.9% | -$3200.00+77.4% | -$14160.00-56.3% | -$9060.00 |
| Diluted (in dollars per share) | -$1690.00-1790.0% | $100.00+108.2% | -$1220.00+57.2% | -$2850.00+10.9% | -$3200.00+77.4% | -$14160.00-56.3% | -$9060.00 |
| Basic (in shares) | 262.39B+9.2% | 240.39B+8.5% | 221.66B+4.3% | 212.47B+18.7% | 178.97B+511.6% | 29.26B+1.6% | 28.81B |
| Diluted (in shares) | 262.39B-1.3% | 265.85B+19.9% | 221.66B+4.3% | 212.47B+18.7% | 178.97B+511.6% | 29.26B+1.6% | 28.81B |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.